References
- Laerum O D, Farsund T. Clinical application of flow cytometry: a review. Cytometry 1981; 2: 1
- Barlogie B, Rabes M N, Schumann J, et al. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982
- Friedlander M L, Hedley D W, Taylor JW. Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol 1984; 37: 961
- de Vere White R W, Deitch AD. The role of flow cytometry in urologic disease. Seminars in Urology III. Masson, New York 1985; 132
- Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J Urol 1987; 5: 108
- Franzen S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumors by transrectal aspiration biopsy: A preliminary report. J Urol 1960; 32: 193
- Esposti PL. Cytologic malignant grading of prostatic carcinoma by transrectal aspiration biopsy: A five-year follow-up of 469 hormone-treated patients. Scand J Urol Nephrol 1971; 5: 199
- Union Internationale Contre le Cancer. TNM Classification of malignant Tumours.3rd ed. Geneva 1978
- Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract, L G Koss, D V Coleman. Adv Clin Cytol. 1984; 2: 163
- Ritchie A A, Lester J L, Turcillo P, DeKernion JB. The significance of atypia in fine-needle aspiration cytology of the prostate. J Urol 1988; 140: 761
- Tribukait B. Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother 1984; 1: 211
- Levan A, Biesele J. Role of chromosomes in cancerogenesis as studied in serial tissue culture of mammalian cells. Ann NY Acad Sci 1958; 71: 1022
- Tribukait B, Rönström L, Esposti PL. Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma. Analyt Quant Cytol 1983; 5
- Adolfsson J, Rönström L, Hedlund P-O, Löwhagen T, Carstensen J, Tribukait B. The prognostic value of modal DNA in low-grade, low-stage untreated prostate cancer. J Urol 1990, in press
- Bateman H. The solution of a system of differential equations in the theory of radioactive transformation. Cambridge Phil Soc Proc 1910; 15: 423
- Fordham M VP, Burdge A H, Matthews J, Williams G, Cooke T. Prostatic carcinoma cell DNA content measure by flow cytometry and its relation to clinical outcome. Br J Surg 1986; 13: 400
- Lee S E, Currin S M, Paulson D F, Walther PJ. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. J Urol 1988; 140: 769
- Spigelman S S, McNeal J E, Freiha F S, Stamey TA. Rectal examination in volume determination of carcinoma of the prostate: clinical and anatomical correlations. J Urol 1986; 136: 1228
- Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. Urologic pathology: the prostate, M Tannenbaum. LeaccccFebiger, Philadelphia 1977
- Gaeta J F, Asinvatham J E, Miller G, Murphy GP. Histologic grading of primary prostatic cancer: a new approach to an old problem. J Urol 1980; 123: 689
- McNeal JE. The prostate gland morphology and pathobiology. Monogr Urol 1983; 4: 3
- Whitmore WF, Jr. Natural history and staging of prostate cancer. Clin North Am, G P Murphy. Saunders, Philadelphia 1984; 11: 205